KUTV — July is Sarcoma Awareness Month, a time to raise understanding about rare cancers like synovial sarcoma—a life-threatening soft tissue cancer that often appears as a painful lump near the knee, ...
August 2, 2024: The U.S. Food and Drug Administration (FDA) has granted accelerated approval for the immunotherapy afamitresgene autoleucel for the treatment of adults with synovial sarcoma. The ...
Use of histologic and immunologic factors in sarcoma to predict response rates to immunotherapy. A phase II study of an oncolytic herpes simplex virus 2 and an anti-PD-1 antibody in patients with ...
Letetresgene autoleucel (lete-cel) showed a 42% response rate in a phase 2 trial for synovial sarcoma and myxoid/round cell liposarcoma. The trial included 64 patients, with 41% response in synovial ...
In the sport of sumo, a bout most commonly ends when one competitor is pushed or thrown outside of a ring of straw bales partially buried in clay. New research shows that using a drug as a blocker to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results